The FDA has granted fast-track designation to an investigational small molecule to treat individuals with Fragile X syndrome, ...
Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback